Luciane B. Silva

Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening

F. H. Leite, Carlos H.T.P. da Silva, Cleydson B. R. Santos, 2018, Molecules.

Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening

L. Federico, Cleydson B. R. Santos, J. Costa, 2019, Molecules.

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents

C. H. D. da Silva, C. B. R. dos Santos, Lúcio R de Lima, 2022, Frontiers in Molecular Biosciences.

Acmella oleracea (L) R. K. Jansen Reproductive Toxicity in Zebrafish: An In Vivo and In Silico Assessment

J. Carvalho, C. B. R. dos Santos, W. Barbosa, 2019, Evidence-based complementary and alternative medicine : eCAM.

Virtual Screening and Statistical Analysis in the Design of New Caffeine Analogues Molecules with Potential Epithelial Anticancer Activity

W. J. C. Macêdo, D. Brasil, J. V. Cruz, 2018, Current pharmaceutical design.

Isolation, Identification, predictions of biological activity and molecular docking of the diterpene jateorin obtained from the stem of odontocarya tamoides (D.C.) miers

J. Ellena, Cleydson B. R. Santos, J. Cruz, 2019, Chemical Data Collections.

In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity

Juliana P Zuliani, F. H. Leite, Cleydson B. R. Santos, 2019, Molecules.

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

J. Campos, Cleydson B. R. Santos, J. A. H. M. Bittencourt, 2023, Molecules.

Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches

J. Campos, F. H. Leite, Cleydson B. R. Santos, 2020, Molecules.

Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains

Cleydson B. R. Santos, J. Cruz, Luciane B. Silva, 2023, Pharmaceuticals.